BRIMINGHAM:The antibodies we create after we’re infected with a virus or vaccinated against it can be very powerful. A virus…
NEW DELHI:Global land-use changes through human settlement, agricultural expansion and livestock production are creating hot spots favourable for coronavirus-carrying bats,…
NEW DELHI:A total of 771 variants of concerns (VOCs) have been detected in a total of 10,787 positive samples shared…
HYDERABAD:Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, today announced the first interim analysis of…
NEW DELHI:The number of people who have tested positive for the new UK variant of SARS-CoV-2 in the country has…
LONDON:Remdesivir may be a highly effective antiviral against SARS-CoV-2, the virus that causes COVID-19, according to a new single-patient study…
LONDON:Researchers have revealed that the vast majority of individuals have detectable antibodies up to three months post contracting the SARS-CoV-2…
LONDON:People infected with the SARS-CoV-2 virus, that causes COVID-19, are most likely to be highly infectious in the first week…
NEW DELHI:While some reports have come out saying antibodies to coronavirus go away quickly, a new study has revealed that…
LONDON: The University of Cambridge on Wednesday confirmed plans to begin trials of a potential new vaccine not only against…
This website uses cookies.